B

유유제약

000220KOSPI의약품 제조업

63.0 / 100

Reference Date: 2026-04-13

Financial Score29.0 / 40
News Sentiment17.0 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Revenue metrics are weak. Slightly down 3.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Yuu Pharmaceutical, established in 1941, is a company specializing in the production and sale of pharmaceuticals and health functional foods, operating a manufacturing plant in Cheongcheon, Chungcheongbuk. It supplies specialized medicines to domestic hospitals and clinics, engages in contract manufacturing, and exports finished pharmaceutical products globally. The company also expands its business through subsidiaries like Yuu Healthcare and Yuu Medicals, covering health functional foods, medical devices, and veterinary pharmaceuticals.

Number of Employees

248people

Average Salary

61.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
8.57Industry Average 14.806.5Point

Lower than industry avg (good)

PBR
0.51Industry Average 1.047.0Point

Half of industry avg (excellent)

ROE
6.62Industry Average 4.424.0Point

In line with industry avg

Debt Ratio
5.50Industry Average 11.986.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.4% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲1551.5% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 3.4% (improving, 3yr)

Detailed News Sentiment

13 totalPositive 7Neutral 2Negative 0Average Sentiment Score 76.1

Detailed Momentum

52-week position3.0Point

52w lower range (22%)

Current 4,215Won52-week high 4,77052-week low 4,055
1-month return2.0Point

1m -3.33% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
  • Neutral정기주주총회결과2026-03-26
  • Neutral기업가치제고계획(자율공시)2026-03-24
  • Neutral감사보고서제출2026-03-18
  • Neutral사업보고서 (2025.12)2026-03-18